Postoperative Troponin in Children With Congenital Heart Disease

Completed

• Conditions: Congenital Heart Disease

• Registration Number: NCT01616394
• Lead Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Brief Summary

The aim of the study is to evaluate the value of postoperative troponin in the prediction of mid term and long term mortality and morbidity in children with congenital heart disease undergoing cardiac surgery.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02
• Study First Submitted: 2012-02-08
• Study First Submitted QC: 2012-06-07
• Study First Posted: 2012-06-11
• Status Verified: 2013-09
• Primary Completion: 2014-10
• Study Completion: 2014-10
• Last Update Submitted: 2014-11-18
• Last Update Posted: 2014-11-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

• all children with congenital heart disease between 0-10 years admitted for elective or emergency corrective or palliative cardiac surgery

Exclusion Criteria

• parental refusal
• children older than 10 years

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mortality	3 months

Secondary Outcome Measures

Name	Time	Method
morbidity and mortality and length of stay in the PICU and in the hospital	in hospital; 3 months; 6 months

Trial Locations

Locations (1)

Cliniques Universitaires saint Luc; 🇧🇪 Brussels, Belgium